Joint Operations Medical Expands Arthrosamid Clinic Network

Joint Operations Medical GmbH has significantly expanded its network of clinics that provide the Arthrosamid® treatment. The company announced that the treatment is now available at over 700 clinics worldwide, enhancing patient access to therapies for knee osteoarthritis.

Arthrosamid® is an injectable treatment designed to alleviate symptoms associated with knee osteoarthritis. The addition of new clinics to its network is a strategic move aimed at bringing the treatment closer to patients suffering from this common condition.

The expansion into new locations across various regions supports the company's growth strategy and seeks to meet the increasing demand for non-surgical osteoarthritis management options. Details regarding the specific locations and availability of the treatment can be found on the company's official website.

While Joint Operations Medical GmbH has not released further information on specific treatment protocols or pricing, the growth of its clinic network indicates a commitment to broadening access to Arthrosamid® therapies.